Abstract:A series of new 1,2,4-oxadiazole-based derivatives were synthesized and evaluated for their anti-AD potential. The results revealed that eleven compounds ( 1b , 2a-c , 3b , 4a-c , and 5a-c ) exhibited excellent inhibitory potential against AChE, with IC 50 values ranging from 0.00098 to 0.07920 μM. Their potency was 1.55 to 125.47 times higher than that of donepezil (IC 50 = 0.12297 μM). In contrast, the newly synthesized oxadiazole derivatives with IC 50 values in the range of 16.64 – 70.82 μM exhibited less selectivity towards BuChE when compared to rivastigmine (IC 50 = 5.88 μM). Moreover, oxadiazole derivative 2c (IC 50 = 463.85 μM) was more potent antioxidant than quercetin (IC 50 = 491.23 μM). Compounds 3b (IC 50 = 536.83 μM) and 3c (IC 50 = 582.44 μM) exhibited comparable antioxidant activity to that of quercetin. Oxadiazole derivatives 3b (IC 50 = 140.02 μM) and 4c (IC 50 = 117.43 μM) showed prominent MAO-B inhibitory potential. They were more potent than biperiden (IC 50 = 237.59 μM). Compounds 1a , 1b , 3a , 3c , and 4b exhibited remarkable MAO-A inhibitory potential, with IC 50 values ranging from 47.25 to 129.7 μM. Their potency was 1.1 to 3.03 times higher than that of methylene blue (IC 50 = 143.6 μM). Most of the synthesized oxadiazole derivatives provided significant protection against induced HRBCs lysis, revealing the nontoxic effect of the synthesized compounds, thus making them safe drug candidates. The results unveiled oxadiazole derivatives 2b , 2c , 3b, 4a, 4c , and 5a as multitarget anti-AD agents. The high AChE inhibitory potential can be computationally explained by the synthesized oxadiazole derivatives' significant interactions with the AChE active site. Compound 2b showed good physicochemical properties. All these data suggest that 2b could be considered as a promising candidate for future development.

Synthesis of 3-(5-bromo-2,3-dimethoxy-phenyl)-[1, 2, 4] oxadiazole analogues and their evaluation as anti-Parkinson′s agents

Synthesis, Crystal Structures, Fluorescence and Xanthine Oxidase Inhibitory Activity of Pyrazole-Based 1,3,4-Oxadiazole Derivatives

Design, Synthesis and Biological Evaluation of 2-Styryl-5-hydroxy-4-pyrone Derivatives and Analogues As Multiple Functional Agents with the Potential for the Treatment of Alzheimer's Disease.

Identification of N-phenyl-3-methoxy-4-pyridinones As Orally Bioavailable H3 Receptor Antagonists and Β-Amyloid Aggregation Inhibitors for the Treatment of Alzheimer's Disease.

6-Benzyloxyphthalides as selective and reversible monoamine oxidase B inhibitors with antioxidant and anti-neuroinflammatory activities for Parkinson’s disease treatment

Design, Synthesis, and Biological Evaluation of 1,3,4-Oxadiazole Derivatives

New 1,2,4-oxadiazole derivatives as potential multifunctional agents for the treatment of Alzheimer's disease: design, synthesis, and biological evaluation

Novel 1,3,4-oxadiazole-2- thiol derivatives: Unlocking the therapeutic potential as anti-inflammatory and anticancer agents

1,3,4-Oxadiazole-3(2H)-carboxamide derivatives as potential novel class of monoamine oxidase (MAO) inhibitors: synthesis, evaluation, and role of urea moiety.

Design and synthesis of benzo[d]thiazol-2-yl-methyl-4-(substituted)-piperazine-1-carbothioamide as novel neuronal nitric oxide inhibitors and evaluation of their neuroprotecting effect in 6-OHDA-induced unilateral lesioned rat model of Parkinson's disease

Synthesis of pyridin-3-yl-1,3,4-oxadiazole and 5- p -tolyl-1,3,4-oxadiazole derivatives and their evaluation as antihyperglycemic agents, AChE and BuChE inhibitors, and antioxidants

Design and synthesis of novel 3,4-dihydrocoumarins as potent and selective monoamine oxidase-B inhibitors with the neuroprotection against Parkinson’s disease

Synthesis, biological and computational evaluation of benzoxazole hybrid analogs as potential anti-Alzheimer's agents

Novel Substituted Pyrimidine Derivatives as Potential Anti-Alzheimer’s Agents: Synthesis, Biological, and Molecular Docking Studies

Design, Synthesis And Inhibitory Activities Of 8-(Substituted Styrol-Formamido)Phenyl-Xanthine Derivatives On Monoamine Oxidase B

Synthesis, molecular structure, Hirshfeld surface, energy framework and DFT studies of 1,3,4 oxadiazole derivative

Computer-Aided Design and Biological Evaluation of Diazaspirocyclic D4R Antagonists

Synthesis and Biological Potentials of 5-aryl-N-[4-(trifluoromethyl) phenyl]-1,3,4-oxadiazol-2-amines

Investigation, scaffold hopping of novel donepezil-based compounds as anti-Alzhiemer's agents: synthesis, in-silico and pharmacological evaluations

In Vivo Antipsychotics: Synthesis, Spectral, Docking and Pharmacokinetic Properties of New 1-(4-(3,4-dihydroquinolin-2(1H)-one-7-yloxy)butyl)-3-methyl-2,7-diphenyl-1,4-diazepan-5-one Analogs of Aripiprazole

Synthesis and antioxidant activity of 1,3,4-oxadiazole tagged thieno[2,3-d]pyrimidine derivatives